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he cation-independent mannose 6-phosphate receptor
(CI-MPR) mediates sorting of lysosomal hydrolase
precursors from the TGN to endosomes. After releasing
the hydrolase precursors into the endosomal lumen, the
unoccupied receptor returns to the TGN for further rounds
of sorting. Here, we show that the mammalian retromer
complex participates in this retrieval pathway. The hVps35
subunit of retromer interacts with the cytosolic domain of the
CI-MPR. This interaction probably occurs in an endosomal
compartment, where most of the retromer is localized. In
T
 
particular, retromer is associated with tubular–vesicular
proﬁles that emanate from early endosomes or from inter-
mediates in the maturation from early to late endosomes.
Depletion of retromer by RNA interference increases the
lysosomal turnover of the CI-MPR, decreases cellular levels
of lysosomal hydrolases, and causes swelling of lysosomes.
These observations indicate that retromer prevents the
delivery of the CI-MPR to lysosomes, probably by seques-
tration into endosome-derived tubules from where the
receptor returns to the TGN.
 
Introduction
 
Like other basic cellular processes, the mechanisms by which
newly synthesized acidic hydrolases are sorted to the yeast
vacuole and the mammalian lysosome are evolutionarily
conserved. In the yeast 
 
Saccharomyces cerevisiae
 
, this sorting
is initiated by the binding of soluble hydrolase precursors
such as pro-carboxypeptidase Y and pro-proteinase A to the
transmembrane receptor Vps10p in the late Golgi complex
(Marcusson et al., 1994; Cooper and Stevens, 1996). The
hydrolase–Vps10p complexes are then transported to a late
endosomal or prevacuolar compartment by a process that is
at least partially dependent on the coat proteins, clathrin
(Seeger and Payne, 1992; Deloche et al., 2001), Golgi-local-
ized, 
 
 
 
 ear–containing ARF-binding proteins (Dell’Angelica
et al., 2000; Hirst et al., 2000, 2001; Costaguta et al., 2001;
Mullins and Bonifacino, 2001; Zhdankina et al., 2001),
and AP-1 (Costaguta et al., 2001; Hirst et al., 2001). The
acidic environment of the prevacuolar compartment in-
duces dissociation of the hydrolase–Vps10p complexes, after
which the hydrolases are transported to the vacuole and the
pro sequences are removed by proteolytic cleavage, while
Vps10p returns to the late Golgi complex to mediate further
rounds of sorting (Cooper and Stevens, 1996; Seaman et
al., 1997). Emr and colleagues demonstrated that Vps10p
retrieval is mediated by a heteropentameric complex named
“retromer” (Seaman et al., 1998). The yeast retromer comprises
five cytosolic/peripheral membrane proteins termed Vps5p,
Vps17p, Vps26p, Vps29p, and Vps35p (Seaman et al.,
1998). Vps35p recognizes the cytosolic domain of Vps10p
and forms a stable subcomplex with Vps29p (Nothwehr et
al., 1999, 2000). Vps5p and Vps17p contain Phox homology
domains that bind phosphatidylinositol 3-phosphate, and
interact with one another to form another stable subcomplex.
This Vps5p–Vps17p subcomplex has a tendency to oligomerize
and has therefore been proposed to serve as a scaffold for the
assembly of a putative membrane coat that drives vesicle
formation (Horazdovsky et al., 1997; Seaman et al., 1998;
Seaman and Williams, 2002). Finally, Vps26p has been
proposed to promote the assembly of the cargo-selective
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Vps35p–Vps29p subcomplex with the structural Vps5p–
Vps17p subcomplex (Reddy and Seaman, 2001).
The functional counterparts of Vps10p in mammals are
two transmembrane mannose 6-phosphate receptors (MPRs),
namely the cation-dependent MPR (CD-MPR) and cation-
independent MPR (CI-MPR; Kornfeld and Mellman, 1989;
Ghosh et al., 2003). The names of these receptors derive from
their ability to bind mannose 6-phosphate groups on the lyso-
somal hydrolase precursors in a divalent cation-dependent
or -independent manner, respectively. This binding takes place
at the TGN, which is the mammalian equivalent to the yeast
late Golgi. The cytosolic domains of the MPRs have COOH-
terminal acidic cluster–dileucine signals that bind Golgi-local-
ized, 
 
 
 
 ear–containing ARF-binding proteins (Puertollano et
al., 2001; Takatsu et al., 2001; Zhu et al., 2001) and other less
well-characterized signals that bind AP-1 (Glickman et al.,
1989; Mauxion et al., 1996; Honing et al., 1997). These in-
teractions are thought to cooperate in the packaging of hydro-
lase–MPR complexes into clathrin-coated vesicles or pleio-
morphic carriers that bud from the TGN and deliver the
complexes to either early or late endosomes (Geuze et al.,
1985; Bock et al., 1997; Klumperman et al., 1998; Doray et
al., 2002; Puertollano et al., 2003; Waguri et al., 2003). As
described in the previous paragraph for yeast, the hydrolase–
MPR complexes dissociate at the acidic pH of endosomes,
upon which the hydrolases are carried with the fluid phase to
the lysosome lumen while the MPRs recycle to the TGN. Sev-
eral proteins and protein complexes have been implicated in
endosome-to-TGN retrieval of MPRs in mammalian cells.
Among these are the AP-1 complex (Meyer et al., 2000,
2001)—which thus seems to be involved in both forward and
retrograde transport—and two adaptor-like proteins: tail-
interacting protein of 47 kD (TIP47; Diaz and Pfeffer, 1998;
Krise et al., 2000; Orsel et al., 2000) and phosphofurin acidic
cluster sorting protein-1 (PACS-1; Wan et al., 1998). Intrigu-
ingly, mutations in yeast AP-1 alone do not impair pro-car-
boxypeptidase Y trafficking to the vacuole, implying normal
recycling of Vps10p (Yeung et al., 1999). Furthermore,
TIP47 and PACS-1 have no homologues in yeast. These find-
ings could point to either important mechanistic differences
between endosome-to-TGN transport in yeast and mammals
or to the existence of evolutionarily conserved components of
the MPR retrieval machinery that remain to be identified.
These considerations led us to hypothesize that the mam-
malian retromer could be involved in MPR trafficking. In-
deed, structural homologues of all the yeast retromer sub-
units (except for Vps17p) have been identified in mammals
(Haft et al., 2000). Despite the absence of a Vps17p homo-
logue, the mammalian retromer is also thought to comprise
five subunits, namely hVps26p, hVps29p, and hVps35p
(“h” prefix designates “human”), plus two Vps5p homo-
logues, the sorting nexins 1 and 2 (Snx1 and Snx2, respec-
tively). The subunit interactions, tendency to oligomeriza-
tion, and overall structure are similar to those of the yeast
retromer components (Horazdovsky et al., 1997; Haft et al.,
1998, 2000; Kurten et al., 2001; Seaman and Williams,
2002). Here, we demonstrate that the mammalian retromer
has an important role in the trafficking of the CI-MPR.
 
Results
 
Interaction of the cytosolic domain of the CI-MPR 
with hVps35
 
Genetic and biochemical analyses have identified Vps35p as
the cargo recognition component of the yeast retromer
(Nothwehr et al., 2000). To determine whether this function
is conserved in mammals, we tested for interaction of the
164-residue cytosolic domain of the CI-MPR (Fig. 1 A) with
Figure 1. hVps35 binds to the cytosolic domain of the CI-MPR. (A) Schematic representation of the cytosolic domain of the CI-MPR indicating 
binding sites for interaction partners involved in sorting. (B) Schematic representation of hVps35 indicating segments that bind to other retromer 
subunits and to the CI-MPR. (C and D) Yeast two-hybrid analyses showing the interaction of full-length hVps35 with segments of the CI-MPR 
cytosolic domain, and the interaction of the full-length CI-MPR cytosolic domain with fragments of hVps35. Interaction of the fusion proteins 
was detected by growth of cotransformed cells in the absence of leucine ( Leu) as described in the Materials and methods. hVps29 and 
lamin C were used as negative controls. 
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hVps35 (Fig. 1 B). This analysis was conducted using the
LexA-based yeast two-hybrid system, which is especially
suited for the detection of low affinity interactions. Colony
growth assays showed that hVps35 and the CI-MPR cytoso-
lic domain do interact (Fig. 1 C). No interactions were ob-
served when these constructs were replaced by hVps29 or
lamin C, respectively, indicating that the hVps35–CI-MPR
interaction is specific (Fig. 1 C). We also did not detect inter-
action between the CI-MPR cytosolic domain and hVps26
(unpublished data). The determinants of interactions were
mapped by testing deletion mutants of the CI-MPR cytosolic
domain and hVps35. Two nonoverlapping regions compris-
ing cytosolic domain residues 48–80 and 80–100 of the CI-
MPR cytosolic domain were found to be independently suffi-
cient for interactions with hVps35 (Fig. 1 C), indicating the
existence of two binding sites for hVps35 on the CI-MPR
domain. Many amino acid substitutions within each of these
regions abrogated binding (unpublished data), indicating
that the binding determinants are complex and possibly con-
formational. Notably, the 48–100 region does not contain
the YSKV sequence (residues 26–29) involved in internaliza-
tion of the CI-MPR or the acidic cluster–dileucine motif
(residues 153–162) implicated in its sorting at the TGN (Fig.
1, A and C; Ghosh et al., 2003). The region of hVps35 that
binds to the cytosolic domain of CI-MPR was similarly
mapped to the segment comprising residues 500–693 (Fig. 1
D). Thus, these experiments demonstrated an interaction be-
tween residues 48–100 of the CI-MPR cytosolic domain and
residues 500–693 of hVps35.
 
Partial colocalization of retromer and CI-MPR 
on endosomes
 
The interactions described above prompted us to examine
the potential involvement of retromer in CI-MPR traffick-
Figure 2. Immunofluorescence microscopy analysis of the local-
ization of retromer subunits. (A–F) HeLa cells were incubated for 
30 min at 37 C in the absence (A–C) or presence (D–F) of 100 nM 
wortmannin. Cells were then fixed and stained with rabbit pAbs to 
endogenous hVps26 (A and D), Snx1 (B and E), or Snx2 (C and F), 
followed by donkey Alexa
® 488–conjugated anti–rabbit Igs. (G–I) 
HeLa cells transiently transfected with myc-Snx2 were costained for 
endogenous hVps26 as described above (G), and for myc-Snx2 using 
a mouse mAb to the myc epitope and donkey Cy3-conjugated anti–
mouse Igs (H). (J–L) M1 cells stably transfected with YFP-hVps35 
were stained for hVps26 as described above. Arrowheads indicate 
structures where hVps26 colocalizes with myc-Snx2 (G–I) and with 
YFP-hVps35 (J–L). Bars, 10  m.
Figure 3. Colocalization of hVps26 with organellar markers. HeLa 
cells were fixed and costained with a rabbit pAb to hVps26 (A, D, G, 
J, and M), and with mouse mAbs to the TfR (B), TGN46 (H), Lamp-1 
(K), and the CI-MPR (N), followed by donkey Alexa
® 488–conjugated 
anti–rabbit and donkey Cy3-conjugated anti–mouse Igs. CFP-
Rab5Q79L was expressed by transient transfection (E). Arrowheads 
indicate structures where two proteins colocalize. Bars, 10  m. 
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ing. We started by determining the subcellular localization of
endogenous retromer relative to various organellar markers,
including the CI-MPR. Immunofluorescence microscopy
with antibodies to three retromer subunits, hVps26, Snx1,
and Snx2, showed a similar punctate staining of the cyto-
plasm in HeLa cells (Fig. 2, A–C). A 30-min treatment with
the phosphatidylinositol 3-kinase inhibitor wortmannin
resulted in loss of the punctate staining for all three pro-
teins (Fig. 2, D–F). This result was consistent with the ex-
pected requirement of phosphatidylinositol 3-phosphate for
association of the Snx proteins to membranes (Zhong et al.,
2002). Double-labeling experiments showed that endogenous
hVps26 colocalized with transgenic myc-tagged Snx2 (Fig.
2, G–I) and with transgenic hVps35 tagged with YFP (Fig.
2, J–L), indicating that the punctate staining observed for all
of these proteins reflects the distribution of the retromer
complex.
Additional experiments revealed extensive colocalization
of endogenous hVps26 with the transferrin receptor (TfR),
an early endosomal marker (Fig. 3, A–C; arrowheads). hVps26
was also found to localize to early endosomes enlarged by
expression of the constitutively active Rab5Q79L mutant
(Stenmark et al., 1994; Fig. 3, D–F). In contrast, we ob-
served little or no colocalization of hVps26 with the TGN
marker TGN46 (Fig. 3, G–I) or the late endosomal/lyso-
somal marker Lamp-1 (Fig. 3, J–L). The CI-MPR has been
previously shown to distribute to the TGN and endosomes
at steady state (Geuze et al., 1988; Klumperman et al.,
1993). hVps26 exhibited partial colocalization with the CI-
MPR, particularly in peripheral cytoplasmic foci (Fig. 3,
M–O; arrowheads). From these experiments, we concluded
that hVps26 (and, by extension, the retromer complex) is
mainly localized to endosomes, where it partially colocalizes
with a peripheral population of CI-MPR.
 
Association of retromer with tubular profiles adjacent 
to endosomes
 
The localization of retromer was analyzed at higher resolu-
tion by cryo-gold immuno-EM using a pAb to hVps26.
Most of the hVps26 labeling (275 out of 365 gold particles
counted, or 75%) was observed in association with tubular
profiles in the vicinity of organelles that had the appearance
of endosomes. Some of these organelles had a relatively
clear lumen, whereas others contained intraluminal vesicles
(Fig. 4, A and B). The tubules were often connected to the
vacuolar portion of the organelles (Fig. 4, A and B; arrows).
A smaller fraction of hVps26 (90 out of 365 gold particles
counted, or 25%) was found on the limiting membrane of
the endosomes themselves (Fig. 4, A–C), in some cases con-
centrated at the necks of protruding tubules (Fig. 4 A, small
arrowhead). The multivesicular organelles often exhibited
thick, flat coats resembling the “bilayered” clathrin- and
Hrs-containing coats previously implicated in sorting to
the ubiquitin–multivesicular body pathway (Raposo et al.,
2001; Raiborg et al., 2002; Sachse et al., 2002; Fig. 4, A
and C, large arrowhead). Retromer was not excluded from
these bilayered coats, although it tended to concentrate on
other domains of the organelle membrane adjacent to
emerging tubules.
To characterize these structures in more detail, we
performed double labeling for hVps26 and other organel-
lar markers. The multivesicular endosomes that contained
hVps26 also labeled for the TfR, indicating that they corre-
sponded to an early endosomal compartment (Fig. 4, B and
C). The CI-MPR was found in the intraluminal vesicles of
the endosomes as well as in the retromer-containing tubules
emanating from these endosomes (Fig. 5 A), a distribution
that was in agreement with that observed in previous papers
(Geuze et al., 1988; Klumperman et al., 1993). We did not
Figure 4. Immuno-EM localization of hVps26 
and TfR. Ultrathin cryosections of HeLa cells were 
immunogold labeled with anti-hVps26 (A) or double-
immunogold labeled with anti-hVps26 (10-nm 
gold particles) and anti-TfR (B and C, 15-nm gold 
particles). Arrows indicate the localization of hVps26 
to tubular structures; large arrowheads indicate the 
presence of a bilayered clathrin coat on multivesicu-
lar endosomes; small arrowheads show the presence 
of hVps26 at the neck of tubules originating from 
endosomes. TfR colocalizes with hVps26 both in 
the tubules and in the endosomes. Bars, 100 nm. 
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observe significant colocalization of retromer with Lamp-1
(Fig. 5 B), ruling out an association of retromer with mature
late endosomes and lysosomes. From these observations, we
concluded that retromer is mainly associated with the previ-
ously described bilayered coated endosomes, which repre-
sent an intermediate stage in the maturation of early to late
endosomes (Raposo et al., 2001; Raiborg et al., 2002; Sachse
et al., 2002). The tubules emanating from these endosomes
are likely the conduits through which the CI-MPR transits
on its way back to the TGN, as previously proposed (Geuze
et al., 1988).
 
In vivo dynamics of retromer-containing structures
 
The dynamics of retromer-containing structures were exam-
ined by live imaging of M1 cells expressing YFP-hVps35
(Fig. 6). Immunoprecipitation-recapture experiments dem-
onstrated that YFP-hVps35 was efficiently incorporated into
the retromer complex (unpublished data), and thus reflected
the behavior of the complex. Indeed, the cytoplasmic punc-
tate distribution of YFP-hVps35 was similar to that of other
retromer subunits, as demonstrated by colocalization with
endogenous hVps26 (Fig. 2, J–L). The YFP-hVps35 puncta
were often adjacent to dark vacuoles that probably corre-
spond to the vacuolar part of endosomes observed by EM
(Fig. 6 A). Both the fluorescent and dark structures re-
mained tightly associated as they moved together in the cy-
toplasm over time (Fig. 6 A; Video 1, available at http://
www.jcb.org/cgi/content/full/jcb.200312055/DC1). The YFP-
hVps35 puncta often gave rise to long fluorescent tubules
that extended in various directions, some toward the juxta-
nuclear area of the cell and others toward other puncta (Fig.
6 A; Video 1). Treatment with the microtubule-depoly-
merizing agent nocodazole prevented the formation of tu-
bules (unpublished data). FRAP of the YFP-hVps35 puncta
showed that this protein reassociated with the same puncta
with a half-time of 6.5 
 
  
 
0.4 s (Fig. 6, B and C). These re-
sults confirmed and extended the observations on fixed cells
by demonstrating that YFP-hVps35 is dynamically associ-
ated with structures adjacent to vacuolar profiles from which
tubules arise.
 
Inhibition of retromer expression by siRNA increases 
lysosomal turnover of the CI-MPR
 
Next, we sought to establish a functional connection be-
tween retromer and the CI-MPR by depleting cells of
hVps26 using a specific small interfering RNA (siRNA). Af-
ter 72 h of treatment with this siRNA, the levels of hVps26
decreased, as observed by both immunofluorescence micros-
copy (Fig. 7, A and B) and immunoblotting (Fig. 7 I).
Quantification of the corresponding immunoblots showed
that the amount of hVps26 decreased by 90 
 
 
 
 5% (
 
n
 
 
 
 
 
 6).
The levels of the other retromer subunits were affected by
the hVps26 depletion to different extents, with hVps29 and
hVps35 levels being substantially decreased and Snx1 and
Snx2 levels being largely unaltered (Fig. 7 I).
The depletion of hVps26 had no effect on the steady-state
distribution or levels of various transmembrane proteins in-
cluding TGN46, the TfR, Lamp-1, and the EGF receptor
(Fig. 7, C–F, I, and unpublished data). It also had no appar-
ent effect on TfR internalization and recycling, as well as on
internalization and degradation of the EGF receptor, as
assessed by fluorescence microscopy (Fig. S1, available at
http://www.jcb.org/cgi/content/full/jcb.200312055/DC1).
However, the levels of CI-MPR were significantly reduced
(to 38 
 
 
 
 21%; 
 
n
 
 
 
 
 
 8) in cells depleted of hVps26, as ob-
served by both immunofluorescence microscopy (Fig. 7, G
and H) and immunoblot analysis (Fig. 7 I). The remaining
CI-MPR exhibited a more dispersed distribution in the cy-
toplasm, suggesting a shift towards endosomes (Fig. 7 H).
Similar results were obtained by siRNA-mediated depletion
of hVps35 (Fig. S2). We reasoned that the reduction in CI-
MPR levels could be due to degradation of the receptor. To
test this hypothesis, we performed a cycloheximide chase ex-
periment in which the levels of CI-MPR in mock- and
siRNA-treated cells were examined at different times after
inhibition of protein synthesis (Fig. 8 A). In mock-treated
cells, the receptor had a half-life of 27 h (Fig. 8 A; Fig. S3),
which was similar to that previously reported by Creek and
Sly (1983). In contrast, in the siRNA-treated cells, the half-
life of the CI-MPR was reduced to 7 h (Fig. 8 A; Fig. S3;
half-lives are the mean from three determinations). To de-
termine whether this degradation occurred in lysosomes, we
Figure 5. Immuno-EM localization of hVps26 relative to CI-MPR 
and Lamp-1. Ultrathin cryosections of HeLa cells were double-
immunogold labeled with anti-hVpS26 (10-nm gold particles) and 
either anti-CI-MPR or Lamp-1 (15-nm gold particles) (A and B, 
respectively). Notice the partial colocalization of hVps26 with CI-MPR 
in multivesicular endosomes (A). The endosomes that are labeled with 
hVps26 are devoid of Lamp-1 (B), pointing to the early endosomal 
nature of these structures. Bars, 100 nm. 
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incubated the siRNA-treated cells with the lysosomal inhibi-
tors leupeptin and E64, plus or minus methionine methyl
ester. We observed that these treatments prevented the de-
crease of CI-MPR levels (Fig. 8 B) and resulted in the accu-
mulation of the CI-MPR in large vesicles (Fig. 8, C–H) that
contained Lamp-1-YFP (Fig. 8, I–K). Together, these obser-
vations indicate that the absence of retromer causes in-
creased delivery of the CI-MPR to lysosomes.
Finally, we assessed the consequences of CI-MPR degra-
dation on lysosomal function. The activities of 
 
 
 
-hexos-
aminidase and 
 
 
 
-glucuronidase, which are normally sorted
to lysosomes by the MPRs, were reproducibly decreased by
25% in extracts of cells treated for 72 h with a single dose of
hVps26 siRNA (Fig. 9 A). In contrast, aconitase activity,
which is present in the cytosol and mitochondria, was not
affected by depletion of hVps26 (Fig. 9 A). This indicated
that the reductions of lysosome hydrolase activities were spe-
cific. Treatment with two doses of hVps26 siRNA at 72-h
intervals (for a total of 144 h) resulted in significant loss of
viability, which precluded accurate measurement of lysoso-
mal enzyme activities. However, the cells that remained at-
tached to the cover glasses exhibited reduced staining for ca-
thepsin D (Fig. 9, B and C), another enzyme sorted by the
MPRs. In addition, we noticed swelling of the lysosomes
stained for Lamp-1 in the hVps26 siRNA-treated cells (Fig.
9, D and E), which probably resulted from accumulation of
undegraded materials in lysosomes.
 
Discussion
 
The results presented here support a role for the mammalian
retromer in the retrieval of the CI-MPR from endosomes to
the TGN. This role appears to involve the recognition of a
bipartite determinant in the cytosolic domain of the CI-
MPR (residues 48–100) by the hVps35 subunit of retromer.
The retromer-binding determinant does not overlap with
the YSKV signal involved in CI-MPR endocytosis (Jadot et
al., 1992) or the acidic cluster–dileucine signal responsible
for sorting of the receptor from the TGN to endosomes
(Johnson and Kornfeld, 1992; Chen et al., 1993, 1997). In
addition, the retromer-binding determinant differs from
those sorting signals in that it is much longer and contains
many critical residues, perhaps indicating that it is confor-
mational in nature. We have been unable to demonstrate a
Figure 6. Fluorescence imaging of YFP-hVps35 
in live cells. (A) Live M1 cells stably expressing 
YFP-hVps35 were imaged by confocal microscopy 
at 37 C. Notice the presence of YFP-hVps35 in 
punctate and tubular structures that are often 
associated with dark vacuolar profiles. The tubule 
marked by the arrowhead extends and detaches 
from a vacuole, and then heads toward the juxta-
nuclear area. The dark vacuole moves along with 
the YFP-hVps35–positive structure. The times at 
which each image was collected are indicated. 
(B) M1 cells stably expressing YFP-hVps35 were 
pretreated with 10  M nocodazole for 1 h at 37 C 
before FRAP. 100% power in the 488-nm line was 
applied for photobleaching in the region indicated 
by the arrow. Recovery was monitored over time. 
The sequence shown represents frames taken every 
2 s. Bar, 10  m. (C) Quantification of the data in B 
shows recovery with a half-time of 6.5 s. 
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similar interaction with the cytosolic domain of the CD-
MPR, but we did detect an interaction with the cytosolic
domain of metallocarboxypeptidase D (unpublished data), a
transmembrane protein that cycles between the TGN and
the plasma membrane (Varlamov and Fricker, 1998).
The hVps35–CI-MPR interactions are likely physiologi-
cal because human retromer partially colocalizes with a
pool of CI-MPR in vesicular–tubular structures distributed
throughout the cytoplasm, though less so with a pericentri-
olar pool of CI-MPR. The morphology and composition of
the structures where retromer colocalizes with CI-MPR cor-
respond to those of early endosomes (Geuze et al., 1983;
Hopkins, 1983; Griffiths et al., 1989; Ludwig et al., 1991)
or intermediates in the maturation of early to late endo-
somes (Geuze et al., 1983; Hirst et al., 1998; Raiborg et al.,
2002, 2003; Sachse et al., 2002). Many of these endosomes
have electron-dense deposits resembling the previously de-
scribed bilayered clathrin- and Hrs-containing coats (Ra-
poso et al., 2001; Raiborg et al., 2002, 2003; Sachse et al.,
2002). They contain the TfR and are enlarged by expression
of Rab5Q79L, but also enclose numerous intraluminal vesi-
cles. All of these are well-established characteristics of the bi-
layered coated endosomes, which represent a transition from
early to late endosomal stages (Raposo et al., 2001; Raiborg
et al., 2002, 2003; Sachse et al., 2002). Retromer is most
concentrated on tubules that radiate from the vacuolar as-
pect of these endosomes, whereas CI-MPR appears evenly
distributed between the radiating tubules and intraluminal
vesicles. These observations indicate that a function of ret-
romer may be to extract CI-MPR from endosomes—per-
haps even from the intraluminal vesicles—through capture
Figure 7. Effect of RNA-mediated interference of hVps26 on the 
expression of retromer subunits. HeLa cells were either mock 
treated or treated with hVps26 siRNA (siRNA) for 72 h, and were 
then analyzed by immunofluorescence microscopy (A–H) and 
immunoblotting (I). Immunofluorescence microscopy was performed 
with antibodies directed to endogenous hVps26 (A and B), TGN46 
(C and D), TfR (E and F), or CI-MPR (G and H), all followed by the 
corresponding secondary antibodies labeled with either Alexa
® 488 
or Cy3. Bars, 10  m. Immunoblots were probed with antibodies to 
the proteins indicated in I and are described in more detail in the 
Materials and methods.
Figure 8. Lysosomal degradation of the CI-MPR upon depletion of 
retromer. (A) Immunoblot analysis of CI-MPR half-life in mock- and 
hVps26-siRNA–treated HeLa cells after treatment with 40  g/ml 
cycloheximide. Tubulin was used as a control. (B) Immunoblot 
analysis of CI-MPR levels after silencing hVps26. HeLa cells were 
incubated in the absence or presence of the lysosomal inhibitors 
leupeptin (Leup, 1 mg/ml), E64 (5  g/ml), and methionine methyl 
ester (MME, 10 mM) for 3 h, as indicated in the figure. Blots were 
probed with antibodies to the CI-MPR or tubulin (control). (C–K) 
Immunofluorescence microscopy of mock-treated (C–E) or hVps26-
siRNA–treated HeLa cells (F–K) incubated in the absence or presence 
of the lysosomal inhibitors described in A, and stained with the 
antibody to the CI-MPR and donkey Cy3-conjugated anti–mouse Igs. 
Lamp-1-YFP (I–K) was expressed by transient transfection. In this 
case, hVps26-depleted cells were treated with MME/Leup/E64 
protease inhibitors. Arrowheads in I–K indicate colocalization of 
Lamp-1-YFP with CI-MPR. Bar, 10  m. 
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into a recycling tubular compartment. Although the tubules
themselves appear mobile, it is at present unclear whether
they constitute the actual transport carriers or give rise to ve-
sicular transport intermediates. The association of retromer
with tubules is consistent with the presence in Snx1 and
Snx2 of a BAR-like domain that has the ability to sense
highly curved membranes (Peter et al., 2004).
The involvement of retromer in recycling of CI-MPR to
the TGN is further supported by the phenotype elicited by
siRNA-mediated interference of retromer expression. This
treatment resulted in enhanced lysosomal degradation of CI-
MPR and, consequently, decreased steady-state levels of this
receptor. Cellular levels of lysosomal hydrolases also decreased
and lysosomes swelled, probably due to accumulation of un-
degraded materials within their lumen. The most logical in-
terpretation of these observations is that retromer keeps the
CI-MPR from going to lysosomes by mediating its removal
from maturing endosomes. We think that the CI-MPR deter-
minant recognized by retromer might encompass a “lysosomal
avoidance” signal functionally similar to that described by
Kornfeld and colleagues in the cytosolic domain of the CD-
MPR (Rohrer et al., 1995). However, the phenylalanine–
tryptophan motif that defines this signal in the CD-MPR
(Rohrer et al., 1995) is not present in the CI-MPR, indicating
that the latter must be structurally different. It is noteworthy
that delivery to lysosomes is the fate of the CI-MPR in the ab-
sence of retromer. This indicates that other determinants
within the CI-MPR direct its targeting to lysosomes in the ab-
sence of retromer. These determinants may be responsible for
inclusion of the CI-MPR into intraluminal vesicles bound for
destruction in lysosomes. In this regard, the luminal domain
of the CI-MPR has been shown to detain chimeric proteins in
endosomes (Dintzis et al., 1994), although we do not know if
this property contributes to the lysosomal degradation of the
receptor in the absence of retromer.
There is a general consensus that the CI-MPR and its
cargo hydrolases follow an intracellular route from the TGN
to the endosomal–lysosomal system (Kornfeld and Mell-
man, 1989; Ghosh et al., 2003). However, the initial port of
entry into this system remains a matter of debate. Indeed,
different reports have presented evidence for transport from
the TGN to either early or late endosomes (Geuze et al.,
1985; Bock et al., 1997; Ludwig et al., 1991; Runquist and
Havel, 1991; Rijnboutt et al., 1992; Hirst et al., 1998;
Klumperman et al., 1998; Press et al., 1998; Meyer et al.,
2001; Waguri et al., 2003). Although our experiments do
not directly address this issue, they highlight the critical im-
portance of passage through early endosomes or early–late
endosomal intermediates in the biosynthetic or endocytic
trafficking of the CI-MPR, as previously proposed (Ludwig
et al., 1991; Runquist and Havel, 1991; Rijnboutt et al.,
1992; Hirst et al., 1998; Lin et al., 2004). Because dissocia-
tion of the lysosomal hydrolases from both the CI-MPR and
CD-MPR occurs between pH 5.0 and 6.0 (Sahagian et al.,
1981; Hoflack and Kornfeld, 1985), some maturation of the
early endosomes must take place before the retromer can as-
sume its role in the retrieval of the unoccupied receptors.
The above considerations notwithstanding, our results do
not rule out that the CI-MPR–hydrolase complexes may be
delivered in part to late endosomes (i.e., those lacking TfR
but containing Lamps). It is indeed possible that more than
one endosomal compartment acts as the acceptor for TGN-
derived carriers, or that some CI-MPR traffics from early to
late endosomes prior to retrieval. Proteins such as AP-1
(Meyer et al., 2000, 2001), TIP47 (Diaz and Pfeffer, 1998;
Orsel et al., 2000; Krise et al., 2000), and PACS-1 (Wan et
al., 1998) could cooperate with retromer in CI-MPR recy-
cling from early endosomes, perhaps by participating in con-
secutive sorting steps along the route to the TGN, or they
could be involved in CI-MPR recycling from late endo-
somes, as previously proposed for TIP47 (Diaz and Pfeffer,
1998; Barbero et al., 2002). The existence of distinct TGN
retrieval pathways originating from early and late endosomes
is well established in both mammalian (Mallet and Maxfield,
1999) and yeast (Hettema et al., 2003) cells.
The alterations in lysosomal/vacuolar sorting resulting
from depletion of retromer in mammalian cells (this paper)
and yeast cells (Seaman et al., 1998) are remarkably similar,
demonstrating the conservation of this aspect of the protein-
sorting machinery. However, a review of the published work
on the mammalian Snx1 and Snx2 makes our results surpris-
Figure 9. Lysosomal alterations in retromer-depleted cells. (A) 
Quantification of  -glucuronidase (black bars),  -hexosaminidase 
(dark gray bars), and aconitase (light gray bars) activities in lysates 
from mock-treated and hVps26-depleted HeLa cells. The results are 
expressed as the mean   SD of at least three experiments, each of 
which was performed in triplicate. (B) Immunofluorescence micros-
copy of mock-treated (B and D) and hVps26-siRNA–treated (C and E) 
cells stained with an antibody to cathepsin D and donkey Alexa
® 
488–conjugated anti–rabbit Igs (B and C), or an antibody to Lamp-1 
and donkey Cy3-conjugated anti–mouse Igs (D and E). Bars, 10  m. 
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ing. Snx1 and Snx2 have been shown to interact with the cy-
tosolic domains of the EGF, transferrin, and leptin recep-
tors, and of protease-activated receptor-1 (Kurten et al.,
1996; Haft et al., 1998; Wang et al., 2002). In the case of
the EGF receptor, interaction with Snx1 is thought to en-
hance its degradation in lysosomes (Kurten et al., 1996),
contrary to the role of retromer in CI-MPR trafficking (this
paper). A possible explanation for this difference could be
that Snx1 and Snx2 are not only components of retromer,
but also are subunits of other still undefined complexes in-
volved in targeting to late endosomes and lysosomes. Resolv-
ing this issue will require a more detailed analysis of the di-
versity of retromer subunit assembly and function.
 
Materials and methods
 
Recombinant constructs
 
Full-length and truncated hVps35 constructs were made by PCR and sub-
cloned in pLexA as described previously (Haft et al., 2000). The CI-MPR
cytosolic domain (last 164 amino acids) as well as truncation mutants of
this domain (constructed using the QuikChange
 
®
 
 kit; Stratagene) were sub-
cloned into the EcoR1–Xho1 sites of the pB42AD vector. Myc-Snx2 in
pCDNA(3.1
 
 
 
) (Invitrogen) was described previously (Haft et al., 2000).
Xho1 and BamH1 sites were added to the 5
 
 
 
 and 3
 
 
 
 ends, respectively, of
full-length hVps35 by PCR and subcloned into the corresponding site in
pEYFP-C1 (CLONTECH Laboratories, Inc.). Lamp-1-YFP in pEYFP-N2 was
a gift from George Patterson (National Institutes of Health, Bethesda, MD).
 
Yeast two-hybrid assays
 
The MATCHMAKER pLexA system was used (CLONTECH Laboratories,
Inc.). Plasmid transformation of the EGY48[p8op-lacZ] strain was by the
lithium acetate method. Co-transformants were selected using SD medium
 
 
 
Ura/
 
 
 
Trp/
 
 
 
His (
 
 
 
2/
 
 
 
Ura plates); individual colonies were picked and
resuspended in water to a final OD
 
600
 
 of 0.1. Finally, 5 
 
 
 
l of this suspen-
sion was plated in parallel on 
 
 
 
2/
 
 
 
Ura plates and SD-Gal/Raf 
 
 
 
Ura/
 
 
 
Trp/
 
 
 
His/
 
 
 
Leu (
 
 
 
3/
 
 
 
Ura plates). Growth was checked after 72 h at
30
 
 
 
C. Lamin C in pB42AD was used as a negative control.
 
Cell transfection
 
Human HeLa or M1 fibroblast cells (American Type Culture Collection,
Manassas, VA) were cultured on 6-well plates at 37
 
 
 
C in DME/high glu-
cose (Biosource International) supplemented with 10% (vol/vol) FBS, 100
U/ml penicillin, and 100 
 
 
 
g/ml streptomycin. When cells reached 60%
confluency, they were transfected with 1 
 
 
 
g DNA constructs using the Fu-
GENE™ reagent (Roche) according to the manufacturer’s instructions. For
stable expression of YFP-hVps35 in M1 cells, cells were transfected and
grown in medium containing 0.5 mg/ml G418 (Geneticin; GIBCO BRL) as
the selective agent. Positive clones were analyzed for expression of YFP-
hVps35 by fluorescence microscopy.
 
RNA interference
 
The sequences 5
 
 
 
-CTCTATTAAGATGGAAGTG-3
 
 
 
 and 5
 
 
 
-ATTTGGT-
GCGCCTCAGTCA-3
 
 
 
 were selected as targets for silencing hVps26 and
hVps35 expression, respectively, with siRNA. Transfection of HeLa cells
with hVps26 or hVps35 siRNA (Dharmacon) was performed using Oligo-
fectamine™ (Invitrogen) following the manufacturer’s protocol. Cells were
analyzed after 72 h or after two consecutive transfections at 72-h intervals.
 
Antibodies and immunofluorescence microscopy
 
Immunofluorescence microscopy was performed as described previously
(Caplan et al., 2002). mAbs used were as follows: 9E10 to the myc epitope
(BabCo); 2G11 to the CI-MPR (Research Diagnostics); B3/25 to the TfR
(Boehringer); and H4A3 to Lamp-1 (Developmental Studies Hybridoma
Bank, Iowa City, IO). The rabbit pAbs to the human retromer proteins
hVps26, hVps29, hVps35, Snx1, and Snx2 have been described previously
(Haft et al., 2000). Other pAbs used were sheep antibody to human
TGN46 (Serotec) and rabbit antibody to cathepsin D (Upstate Biotechnol-
ogy). Donkey Cy3-conjugated AffiniPure anti–mouse Igs (Jackson Immu-
noResearch Laboratories) and donkey Alexa
 
®
 
 488–conjugated anti–rabbit
Igs (Molecular Probes, Inc.) were used as secondary antibodies. For wort-
mannin treatment, cells were incubated in complete DME containing 100
nM wortmannin (Sigma-Aldrich) for 30 min at 37
 
 
 
C. Fluorescently labeled
cells were examined using an inverted confocal laser scanning microscope
(model LSM 510; Carl Zeiss MicroImaging, Inc.) equipped with argon,
HeNe, and krypton lasers, and a 63Å 1.4 NA objective. Alexa
 
®
 
 488 and
Cy3 fluorescence was visualized using excitation filters at 488 and 543 nm
and emission filters at 505–530 and 560 nm, respectively.
 
Electron microscopy
 
HeLa cells were fixed with 4% formaldehyde and 0.2% glutaraldehyde,
and were then processed for ultrathin frozen sectioning as described previ-
ously (Dell’Angelica et al., 2000). The mAb H68.4 to the TfR was obtained
from Zymed Laboratories, and the mAb 2G11 to the CI-MPR was a gift
from Suzanne Pfeffer (Stanford University, Stanford, CA). All other antibod-
ies used have been mentioned above. The protein A–gold used to visualize
the presence of antibody in the electron microscope was obtained from the
University of Utrecht (Utrecht, Netherlands).
 
Live-cell imaging
 
Stably transfected YFP-hVps35 M1 cells were grown on LabTek™ cham-
bers (Nunc) and transferred into culture medium buffered with 25 mM
Hepes/KOH, pH 7.4. Experiments were performed on a spinning disk con-
focal microscope (Ultraview LCI Confocal scanner; PerkinElmer) equipped
with a stage heated to 37
 
 
 
C, and a 63Å
 
 
 
1.4 NA objective. YFP-hVps35 was
excited with a 488-nm line and imaged through a 500 LP emission filter.
FRAP experiments were performed with an inverted confocal laser scan-
ning microscope (model LSM 510; Carl Zeiss MicroImaging, Inc.). Cells
were pretreated with 10 
 
 
 
M nocodazole for 1 h at 37
 
 
 
C before recording.
100% power in the 488-nm line was applied for photobleaching. Images
were collected using a 505–530-nm emission filter. Data were processed
to QuickTime format in NIH Image 1.3 software.
 
Immunoblotting
 
Antisera dilutions used for immunoblotting were as follows: 1:1,000 for
rabbit anti-hVps35, -hVps29, and -hVps26; 1:2,000 for rabbit anti-Snx1
and -Snx2; 1:200 for rabbit antibody to the cytosolic domain of CI-MPR (a
gift of Thomas Braulke, University of Hamburg, Hamburg, Germany); 1:1,000
for mouse anti 
 
 
 
-tubulin (DM1A; Sigma-Aldrich); 1:1,000 for mouse H4A3
anti-Lamp-1; and 1:500 for rabbit anti-EGF receptor (sc-03; Santa Cruz
Biotechnology, Inc.). Immunoblots were developed using HRP-coupled
secondary antisera and an ECL reagent (Western Lightning™; Perkin-
Elmer).
 
Treatment with lysosomal inhibitors
 
Mock- and siRNA-treated cells were incubated for 3 h at 37
 
 
 
C in complete
DME containing 1 mg/ml leupeptin (Roche) and 5 
 
 
 
g/ml E64 (Sigma-
Aldrich) plus or minus 10 mM methionine methyl ester (Sigma-Aldrich).
Cells were scraped, lysed, and analyzed by SDS-PAGE (6% acrylamide or
4–20% acrylamide gradient) and immunoblotting. In addition, coverslips
were fixed and analyzed by immunofluorescence microscopy.
 
Measurements of enzyme activity
 
Crude cell lysates were prepared by centrifugation of HeLa cells for 10 min
at 2,000 
 
g
 
. The cell pellet was resuspended in 50 mM Tris-HCl, pH 7.4,
1% (wt/vol) Triton X-100, 300 mM NaCl, 5 mM EDTA, and protease inhib-
itors, and was incubated on ice for 30 min. Complete lysis was achieved
by 10 passages through a 20-gauge needle. The sample was then centri-
fuged for 15 min at 16,000 
 
g
 
. Protein was quantified by the BCA assay
(Pierce Chemical Co.) using BSA as a standard. 
 
 
 
-glucuronidase and
 
 -hexosaminidase activities were measured using 5 mM 4-methylumbel-
liferyl- -D-glucuronide and 10 mM 4-methylumbelliferyl-2-acetamido-2-
deoxy- -D-glucopiranoside (Sigma-Aldrich) as substrates, respectively
(Nolan, 1992). Fluorescence spectra were acquired on a fluorimeter (Flu-
oroMax-3; Jobin Yvon), setting excitation wavelength at 360 nm and emis-
sion and excitation slits between 1 and 1.5 nm. Fluorescence intensity at
445 nm was recorded. Aconitase activity was measured in cell lysates pre-
pared in the presence of citrate as described by Meyron-Holtz et al. (2004).
Cycloheximide chase
Mock- and siRNA-treated cells were trypsinized and incubated in suspen-
sion at 37 C in complete DME containing 25 mM Hepes buffer, pH 7.4,
and 40  g/ml cycloheximide (Sigma-Aldrich). At the corresponding time
point, cells were spun for 10 min at 2,000 g, lysed as described above, and
analyzed by SDS-PAGE and immunoblotting.
Online supplemental material
Video 1 shows stably transfected YFP-hVps35 M1 cells grown on Lab-
Tek™ chambers (Nunc) and transferred into culture medium buffered with132 The Journal of Cell Biology | Volume 165, Number 1, 2004
25 mM Hepes/KOH, pH 7.4. Experiments were performed on a spinning
disk microscope (Ultraview LCI Confocal scanner; PerkinElmer) equipped
with a stage heated to 37 C, and a 63Å 1.4 NA objective. YFP-hVps35 was
excited with a 488-nm line and imaged through a 500 LP emission filter.
Fig. S1 shows that the trafficking of the TfR and the EGF receptor is not
affected by retromer depletion. Fig. S2 shows the effects of siRNA-medi-
ated depletion of hVps35 on the distribution and levels of the CI-MPR.
Fig. S3 shows a representation of the kinetics of CI-MPR turnover. Online
supplemental material available at http://www.jcb.org/cgi/content/full/jcb.
200312055/DC1.
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